We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




HBOT Protocols Improve Aging Cardiac Function

By HospiMedica International staff writers
Posted on 13 Feb 2020
Print article
Image: HBOT lounges at the Sagol Center for Hyperbaric Medicine and Research (Photo courtesy of Shamir Medical Center)
Image: HBOT lounges at the Sagol Center for Hyperbaric Medicine and Research (Photo courtesy of Shamir Medical Center)
A new study demonstrates the positive, sustained effect of hyperbaric oxygenation therapy (HBOT) protocols on heart function in healthy aging heart populations.

Researchers at Shamir Medical Center (Zerifin, Israel) and Tel Aviv University (Israel) conducted an observational, prospective study involving 31 patients (mean age 70 years, 90% male) in order to evaluate the effect of HBOT treatment on cardiac function in an aging population with a "normal for their age" cardiac function. Participants underwent a 60-session HBOT treatment course and were evaluated before HBOT was administered and three weeks after treatment concluded to identify sustained effects.

The results showed a small increase in left ventricular ejection fraction (LVEF), a minor decrease in left ventricular end systolic volume (LVESV), and higher global and regional left ventricular strain--which indicates the efficacy of cardiac muscle contraction--due to improvement in regional strain in the apical and antero-septal segments. In addition, cardiac twist increased by five degrees due to an improvement in apical rotation. The study was published on January 17, 2020, in The International Journal of Cardiovascular Imaging.

“Up until now, the effect of the hyperbaric oxygen environment on cardiac function was mostly evaluated during and after short-term exposures,” said lead author Marina Leitman, MD, of Shamir Medical Center. “Unlike a single exposure to high pressure, the regenerative HBOT protocols that are administered at the Sagol Center have the potential to induce beneficial effects in heart function. These results show that even in a healthy asymptomatic population, cardiac function was improved, opening the door for further study on the impact of this novel therapy on conditions related to cardiac disease.”

“As we age, a decrease in mitochondrial function occurs throughout the body, impacting the functionality of organs, including the heart,” said study co-author Shai Efrati, MD, director of the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center. “For the first time in humans, using our HBOT protocol, we have demonstrated the possibility of heart functionality improvement in healthy, aging people. The results of this study are in accordance with other studies demonstrating that HBOT can improve mitochondrial function.”

HBOT involves 100% pure oxygen delivered to a patient at atmospheric pressure three times higher than normal air pressure in an enclosed chamber. At those pressures, the body is able to incorporate more oxygen into blood cells, blood plasma, cerebral-spinal, and other bodily fluids; the increased oxygen absorption significantly enhances the body’s ability to aid in its own healing. In 1937 hyperbaric oxygen treatments were first used for decompression sickness, but it was not until 1956 that HBOT was used as a therapeutic aid in cardiopulmonary surgery.

Related Links:
Shamir Medical Center
Tel Aviv University


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Oxygen Concentrator
ZH-A51
New
Blood and Infusion Warmer
SW300

Print article

Channels

Surgical Techniques

view channel
Image: Catheters coated with the new material showed a significant reduction in clotting on the device surface (Photo courtesy of UBC Faculty of Medicine)

Newly Developed Coating Makes Medical Devices Clot-Free

Thrombosis, or the formation of blood clots, presents a significant challenge for devices that come into contact with blood. Unlike natural blood vessels, these devices can activate specific proteins in... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.